Frank Yocca
Chief Scientific Officer · BioXcel Therapeutics, Inc.
- 2024
- Jun 18, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Frank Yocca files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vimal Mehta - $21K in BTAI purchases and sales in the last 12 months
- Richard I. Steinhart - $7K in BTAI purchases and sales in the last 12 months
- Javier Rodriguez - $7K in BTAI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Frank Yocca?
Frank Yocca is a corporate insider, tracked as Chief Scientific Officer of BioXcel Therapeutics, Inc. (BTAI). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Frank Yocca last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 9 filings going back to 2024.
Has Frank Yocca been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($12K) across all tracked filings.
